Technical Analysis for ATE - Antibe Therapeutics Inc.

Grade Last Price % Change Price Change
F 0.84 -3.45% -0.030
ATE closed down 3.45 percent on Monday, October 25, 2021, on 78 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
Earnings due: Nov 11
*** please verify all earnings dates ***

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Very Strong Down Down Down
Historical ATE trend table...

Date Alert Name Type % Chg
New 52 Week Closing Low Bearish 0.00%
Narrow Range Bar Range Contraction 0.00%
NR7 Range Contraction 0.00%
NR7-2 Range Contraction 0.00%
Lower Bollinger Band Walk Weakness 0.00%
Wide Bands Range Expansion 0.00%
Down 3 Days in a Row Weakness 0.00%
Oversold Stochastic Weakness 0.00%
New 52 Week Closing Low Bearish -3.45%
Calm After Storm Range Contraction -3.45%
Older End-of-Day Signals for ATE ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Possible NR7 about 19 hours ago
Gap Down Partially Closed about 23 hours ago
Gapped Down (Full) about 23 hours ago
Lower Bollinger Band Support about 23 hours ago
2x Volume Pace about 23 hours ago
View Earlier Intraday Alerts

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Antibe Therapeutics Inc. Description

Antibe Therapeutics Inc. is a commercial-stage pharmaceutical company. The Company is focused on pain, inflammation and regenerative medicine. The Company's segments include Antibe Therapeutics, and Citagenix, which is a marketer and distributor of regenerative medicines serving the dental and orthopedic market places. The Company's drug design methodologies involve chemically linking a base drug to its hydrogen sulfide-releasing molecule. Its lead compound, ATB-346, combines hydrogen sulfide with naproxen, which is a non-steroidal anti-inflammatory drug (NSAID). The Company's other products include ATB-352, which is indicated for the treatment of severe acute pain, and ATB-340 is a Gastrointestinal (GI)-safe derivative of aspirin. The Company also offers regenerative medical devices, which include PentOS (CGX-283), CGX-227, CGX-443 and URIST (CGX-276), all of which target bone regeneration, and are indicated for oral and maxillofacial surgery.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Chemistry Medicine Pharma Derivative Pharmaceutical Chemical Drug Pain Sulfide Drugs RTT Leasing Hydrogen Surgery Medical Devices Bone Chemical Compounds Places Hydrogen Sulfide Inflammation Urist Regenerative Medicine Acute Pain Analgesics Hepatotoxins Nonsteroidal Anti Inflammatory Drugs

Is ATE a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 7.52
52 Week Low 0.83
Average Volume 164,543
200-Day Moving Average 3.431
50-Day Moving Average 1.169
20-Day Moving Average 1.075
10-Day Moving Average 0.973
Average True Range 0.068
ADX 52.71
+DI 6.719
-DI 36.120
Chandelier Exit (Long, 3 ATRs) 1.046
Chandelier Exit (Short, 3 ATRs) 1.034
Upper Bollinger Bands 1.338
Lower Bollinger Band 0.811
Percent B (%b) 0.06
BandWidth 49.065
MACD Line -0.119
MACD Signal Line -0.105
MACD Histogram -0.0139
Fundamentals Value
Market Cap 32.4 Million
Num Shares 38.6 Million
EPS -0.07
Price-to-Earnings (P/E) Ratio -11.34
Price-to-Sales 14.05
Price-to-Book 6.89
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.885
Resistance 3 (R3) 0.887 0.873 0.878
Resistance 2 (R2) 0.873 0.862 0.873 0.875
Resistance 1 (R1) 0.857 0.855 0.865 0.855 0.872
Pivot Point 0.843 0.843 0.848 0.843 0.843
Support 1 (S1) 0.827 0.832 0.835 0.825 0.808
Support 2 (S2) 0.813 0.825 0.813 0.805
Support 3 (S3) 0.797 0.813 0.803
Support 4 (S4) 0.795